It will include a mix of newly-approved jabs adapted for the now dominant Omicron strain, and the original vaccines developed to fight the virus that first emerged in China in 2019, the European Medicines Agency (EMA) said. But people "should not wait for a specific vaccine", EMA vaccines chief Marco Cavaleri told a news conference.